An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Charles Turck, PharmD, BCPS, BCCCP
Anthony Stein, MD
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Shaji K. Kumar, MD
Reviewing the Latest Bladder Cancer Practice Guidelines
Understanding the Expanding Role of Antibody-Drug Conjugates in Bladder Cancer
Lillibeth Velasco, MSN, RN
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Urvi A. Shah, MD, MS
Patient Perspectives on Bladder Cancer
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Managing Anemia in Myelofibrosis: A Multidisciplinary Approach
Brian P. McDonough, MD, FAAFP
Douglas Tremblay, MD
Marina Kremyanskaya, MD
Alleviating Anemia in Myelofibrosis: New Therapeutic Avenues
Prithviraj Bose, MD
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
John Mascarenhas, MD
Lucia Masarova, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.